Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE CESARONI SOLQUES : revenue, balance sheet and financial ratios

SELARL PHARMACIE CESARONI SOLQUES is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LA TRINITE (06340), this company of category PME shows in 2019 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE CESARONI SOLQUES (SIREN 838686889)
Indicator 2021 2020 2019
Revenue N/C N/C 1 319 320 €
Net income 104 253 € 79 871 € -32 270 €
EBITDA N/C N/C -21 410 €
Net margin N/C N/C -2.4%

Revenue and income statement

In 2021, SELARL PHARMACIE CESARONI SOLQUES generates positive net income of 104 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

104 253 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 447%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

447.255%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

15.679%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

11.9%

Solvency indicators evolution
SELARL PHARMACIE CESARONI SOLQUES

Sector positioning

Debt ratio
447.25 2021
2019
2020
2021
Q1: 29.04
Med: 85.54
Q3: 208.43
Average

In 2021, the debt ratio of SELARL PHARMACIE CESARONI... (447.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
15.68% 2021
2019
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Watch

In 2021, the financial autonomy of SELARL PHARMACIE CESARONI... (15.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-37.6 years 2019
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.48 years
Excellent

In 2019, the repayment capacity of SELARL PHARMACIE CESARONI... (-37.60) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 159.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

159.782

Liquidity indicators evolution
SELARL PHARMACIE CESARONI SOLQUES

Sector positioning

Liquidity ratio
159.78 2021
2019
2020
2021
Q1: 139.2
Med: 190.68
Q3: 259.61
Average -10 pts over 3 years

In 2021, the liquidity ratio of SELARL PHARMACIE CESARONI... (159.78) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-19.13x 2019
2019
Q1: 1.36x
Med: 5.41x
Q3: 11.35x
Average

In 2019, the interest coverage of SELARL PHARMACIE CESARONI... (-19.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE CESARONI SOLQUES

Positioning of SELARL PHARMACIE CESARONI SOLQUES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of SELARL PHARMACIE CESARONI SOLQUES is estimated at 1 195 825 € (range 768 921€ - 1 847 174€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
768k€ 1195k€ 1847k€
1 195 825 € Range: 768 921€ - 1 847 174€
NAF 5 année 2021

Valuation method used

Net Income Multiple
104 253 € × 11.5x = 1 195 825 €
Range: 768 922€ - 1 847 174€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE CESARONI SOLQUES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE CESARONI SOLQUES

What is the revenue of SELARL PHARMACIE CESARONI SOLQUES ?

The revenue of SELARL PHARMACIE CESARONI SOLQUES in 2019 is 1.3 M€.

Is SELARL PHARMACIE CESARONI SOLQUES profitable?

Yes, SELARL PHARMACIE CESARONI SOLQUES generated a net profit of 104 k€ in 2021.

Where is the headquarters of SELARL PHARMACIE CESARONI SOLQUES ?

The headquarters of SELARL PHARMACIE CESARONI SOLQUES is located in LA TRINITE (06340), in the department Alpes-Maritimes.

Where to find the tax return of SELARL PHARMACIE CESARONI SOLQUES ?

The tax return of SELARL PHARMACIE CESARONI SOLQUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE CESARONI SOLQUES operate?

SELARL PHARMACIE CESARONI SOLQUES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.